$SNTA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in MADRIGAL PHARMACEUTICALS, INC.. Get notifications about new insider transactions in MADRIGAL PHARMACEUTICALS, INC. for free.

Page: < prev 1 2 3 4

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Grant	A	0.00	4,397	0	19,823	15.4 K to 19.8 K (+28.50 %)
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Sell	S	5.25	5,284	27,762	15,426	20.7 K to 15.4 K (-25.51 %)
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Option Exercise	A	5.26	41,891	220,347	41,891
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Grant	A	0.00	4,397	0	21,970	17.6 K to 22 K (+25.02 %)
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Sell	S	5.51	2,537	13,966	17,573	20.1 K to 17.6 K (-12.62 %)
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Option Exercise	A	5.26	58,200	306,132	58,200
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Grant	A	0.00	6,844	0	39,843	33 K to 39.8 K (+20.74 %)
Mar 03 2011	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Sell	S	5.23	18,270	95,552	32,999	51.3 K to 33 K (-35.64 %)
Nov 30 2010	SNTA	SYNTA PHARMACEUTIC ...	Singh Amar	Sr. VP, Business & ...	Option Exercise	A	4.25	150,000	637,500	150,000
Nov 30 2010	SNTA	SYNTA PHARMACEUTIC ...	Singh Amar	Sr. VP, Business & ...	Grant	A	0.00	25,000	0	25,000	0 to 25 K
Nov 12 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Grant	A	3.47	1,440,923	5,000,003	3,325,773	1.9 M to 3.3 M (+76.45 %)
Sep 30 2010	SNTA	SYNTA PHARMACEUTIC ...	KUFE DONALD W	Director	Option Exercise	A	4.00	15,000	60,000	15,000
Sep 17 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.64	24,264	88,411	1,884,850	1.9 M to 1.9 M (+1.30 %)
Sep 15 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.70	38,836	143,650	1,860,586	1.8 M to 1.9 M (+2.13 %)
Sep 15 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.57	36,900	131,855	1,821,750	1.8 M to 1.8 M (+2.07 %)
Aug 20 2010	SNTA	SYNTA PHARMACEUTIC ...	Vukovic Vojo	SVP, Chief Medical ...	Buy	P	2.95	2,800	8,260	17,621	14.8 K to 17.6 K (+18.89 %)
Aug 20 2010	SNTA	SYNTA PHARMACEUTIC ...	Vukovic Vojo	SVP, Chief Medical ...	Buy	P	2.84	714	2,028	14,821	14.1 K to 14.8 K (+5.06 %)
Aug 06 2010	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Sell	S	3.21	4,000	12,840	29,627	33.6 K to 29.6 K (-11.90 %)
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Option Exercise	A	2.59	5,500	14,245	5,500
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Grant	A	0.00	7,722	0	472,399	464.7 K to 472.4 K (+1.66 %)
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Option Exercise	A	2.59	5,500	14,245	5,500
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Grant	A	0.00	3,861	0	12,237	8.4 K to 12.2 K (+46.10 %)
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Option Exercise	A	2.59	5,500	14,245	5,500
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Grant	A	0.00	15,444	0	1,784,850	1.8 M to 1.8 M (+0.87 %)
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	2.59	2,500	6,475	2,500
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	2.59	5,500	14,245	5,500
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	7,722	0	179,523	171.8 K to 179.5 K (+4.49 %)
Jul 06 2010	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	7,722	0	171,801	164.1 K to 171.8 K (+4.71 %)
Jun 16 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.91	65,466	256,103	1,769,406	1.7 M to 1.8 M (+3.84 %)
Jun 16 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.42	2,075	7,105	1,703,940	1.7 M to 1.7 M (+0.12 %)
Jun 14 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.22	59,400	191,030	1,701,865	1.6 M to 1.7 M (+3.62 %)
Jun 14 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	3.00	26,500	79,447	1,642,465	1.6 M to 1.6 M (+1.64 %)
Jun 10 2010	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	3.05	10,000	30,530	2,316,586	2.3 M to 2.3 M (+0.43 %)
Jun 10 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	2.93	88,532	258,956	1,615,965	1.5 M to 1.6 M (+5.80 %)
Jun 10 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	2.80	26,760	74,821	1,527,433	1.5 M to 1.5 M (+1.78 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Option Exercise	A	4.02	38,220	153,644	38,220
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Grant	A	0.00	5,284	0	20,710	15.4 K to 20.7 K (+34.25 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Option Exercise	A	4.02	38,220	153,644	38,220
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Grant	A	0.00	5,284	0	20,110	14.8 K to 20.1 K (+35.64 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Vukovic Vojo	SVP, Chief Medical ...	Option Exercise	A	4.02	69,420	279,068	69,420
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Vukovic Vojo	SVP, Chief Medical ...	Grant	A	0.00	7,477	0	14,107	6.6 K to 14.1 K (+112.78 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Option Exercise	A	4.02	73,425	295,169	73,425
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Grant	A	0.00	7,908	0	23,761	15.9 K to 23.8 K (+49.88 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Option Exercise	A	4.02	76,362	306,975	76,362
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Grant	A	0.00	8,224	0	51,269	43 K to 51.3 K (+19.11 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Option Exercise	A	4.02	80,100	322,002	80,100
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Grant	A	0.00	8,627	0	33,627	25 K to 33.6 K (+34.51 %)
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Option Exercise	A	4.02	160,000	643,200	160,000
Mar 03 2010	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Grant	A	0.00	13,839	0	2,306,586	2.3 M to 2.3 M (+0.60 %)
Jan 12 2010	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	4.50	550,000	2,475,000	1,500,673	950.7 K to 1.5 M (+57.85 %)
Jan 12 2010	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Buy	P	4.50	100,000	450,000	464,677	364.7 K to 464.7 K (+27.42 %)
Jan 12 2010	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	4.50	100,000	450,000	164,079	64.1 K to 164.1 K (+156.06 %)
Jan 12 2010	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	4.50	22,222	99,999	2,292,747	2.3 M to 2.3 M (+0.98 %)
Aug 26 2009	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Buy	P	2.84	10,000	28,434	43,045	33 K to 43 K (+30.26 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Chen Lin Huey	10% Owner	Buy	P	2.88	20,000	57,600	620,035	600 K to 620 K (+3.33 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Chen Lan Bo	Director	Buy	P	2.88	20,000	57,600	620,035	600 K to 620 K (+3.33 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.89	9,245	26,718	2,270,525	2.3 M to 2.3 M (+0.41 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.88	196	564	2,261,280	2.3 M to 2.3 M (+0.01 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.85	2,000	5,700	2,261,084	2.3 M to 2.3 M (+0.09 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.83	1,980	5,603	2,259,084	2.3 M to 2.3 M (+0.09 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.82	300	846	2,257,104	2.3 M to 2.3 M (+0.01 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.80	6,079	17,021	2,256,804	2.3 M to 2.3 M (+0.27 %)
Aug 07 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	2.78	200	556	2,250,725	2.3 M to 2.3 M (+0.01 %)
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	2.38	2,500	5,950	2,500
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	2.38	5,500	13,090	5,500
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	16,806	0	64,079	47.3 K to 64.1 K (+35.55 %)
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Option Exercise	A	2.38	5,500	13,090	5,500
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Grant	A	0.00	16,806	0	950,673	933.9 K to 950.7 K (+1.80 %)
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Option Exercise	A	2.38	5,500	13,090	5,500
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Grant	A	0.00	4,201	0	8,376	4.2 K to 8.4 K (+100.62 %)
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Option Exercise	A	2.38	5,500	13,090	5,500
Jul 06 2009	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Grant	A	0.00	8,403	0	364,677	356.3 K to 364.7 K (+2.36 %)
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Option Exercise	A	2.49	30,870	76,866	30,870
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Option Exercise	A	2.49	30,870	76,866	30,870
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Option Exercise	A	2.49	44,616	111,094	44,616
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Jacobson Eric W	Sr. VP, Research an ...	Option Exercise	A	2.49	47,112	117,309	47,112
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Barsoum James G	Sr. VP, Research	Option Exercise	A	2.49	42,900	106,821	42,900
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Option Exercise	A	2.49	42,900	106,821	42,900
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Option Exercise	A	2.49	146,300	364,287	146,300
Apr 14 2009	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Option Exercise	A	2.49	46,800	116,532	46,800
Jan 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Sell	S	6.20	4,573	28,375	15,853	20.4 K to 15.9 K (-22.39 %)
Jan 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Sell	S	6.18	5,600	34,619	14,826	20.4 K to 14.8 K (-27.42 %)
Jan 06 2009	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Sell	S	6.18	5,000	30,888	15,426	20.4 K to 15.4 K (-24.48 %)
Aug 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.78	31,997	248,828	1,577,967	1.5 M to 1.6 M (+2.07 %)
Aug 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.58	35,000	265,251	1,545,970	1.5 M to 1.5 M (+2.32 %)
Aug 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.28	50,000	364,170	1,510,970	1.5 M to 1.5 M (+3.42 %)
Aug 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	7.37	1,300	9,580	933,867	932.6 K to 933.9 K (+0.14 %)
Aug 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	7.15	25,100	179,470	932,567	907.5 K to 932.6 K (+2.77 %)
Aug 06 2008	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Option Exercise	A	7.69	150,000	1,153,500	150,000
Aug 06 2008	SNTA	SYNTA PHARMACEUTIC ...	BAILEY MICHAEL P	Sr. VP, Chief Comm. ...	Grant	A	0.00	25,000	0	25,000	0 to 25 K
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Option Exercise	A	7.03	5,500	38,665	5,500
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Grant	A	0.00	1,349	0	4,175	2.8 K to 4.2 K (+47.74 %)
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Option Exercise	A	7.03	5,500	38,665	5,500
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Grant	A	0.00	5,398	0	356,274	350.9 K to 356.3 K (+1.54 %)
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Option Exercise	A	7.03	5,500	38,665	5,500
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Grant	A	0.00	5,398	0	907,467	902.1 K to 907.5 K (+0.60 %)
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	7.03	2,500	17,575	8,000
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	7.03	5,500	38,665	5,500
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	2,699	0	47,273	44.6 K to 47.3 K (+6.06 %)
Jun 13 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	5,398	0	44,574	39.2 K to 44.6 K (+13.78 %)
Jun 02 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.10	5,939	42,164	1,460,970	1.5 M to 1.5 M (+0.41 %)
Jun 02 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.18	24,061	172,710	1,455,031	1.4 M to 1.5 M (+1.68 %)
May 20 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	6.95	10,000	69,473	1,430,970	1.4 M to 1.4 M (+0.70 %)
May 20 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	7.07	40,000	282,788	1,420,970	1.4 M to 1.4 M (+2.90 %)
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Williams Martin D	Sr. VP, Business De ...	Option Exercise	A	8.82	42,120	371,498	42,120
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	A	10.84	75,000	813,225	75,000
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	D	10.84	46,875	508,266	0
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	D	16.00	28,125	450,000	0
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Option Exercise	A	8.82	28,980	255,604	28,980
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Jacobson Eric W	Sr. VP, Research an ...	Option Exercise	A	8.82	43,680	385,258	43,680
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Option Exercise	A	8.82	42,120	371,498	42,120
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Option Exercise	A	8.82	28,980	255,604	28,980
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Option Exercise	A	8.82	37,440	330,221	37,440
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Barsoum James G	Sr. VP, Research	Option Exercise	A	8.82	37,440	330,221	37,440
Feb 29 2008	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Option Exercise	A	8.82	100,000	882,000	100,000
Nov 26 2007	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Buy	P	7.83	5,000	39,141	2,250,525	2.2 M to 2.3 M (+0.22 %)
Jul 03 2007	SNTA	SYNTA PHARMACEUTIC ...	Folkman Judah	Director	Grant	A	0.00	4,819	0	7,676	2.9 K to 7.7 K (+168.67 %)
Jul 03 2007	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	4,819	0	39,176	34.4 K to 39.2 K (+14.03 %)
Jul 03 2007	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Grant	A	0.00	4,819	0	350,876	346.1 K to 350.9 K (+1.39 %)
Jul 03 2007	SNTA	SYNTA PHARMACEUTIC ...	REARDON WILLIAM S	Director	Grant	A	0.00	1,204	0	2,826	1.6 K to 2.8 K (+74.23 %)
Jun 12 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	8.58	30,500	261,791	902,069	871.6 K to 902.1 K (+3.50 %)
Jun 12 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	8.56	4,100	35,112	871,569	867.5 K to 871.6 K (+0.47 %)
Jun 12 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	8.30	19,317	160,389	867,469	848.2 K to 867.5 K (+2.28 %)
Jun 12 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	8.28	16,550	137,084	848,152	831.6 K to 848.2 K (+1.99 %)
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Bahcall Safi R	President and CEO	Option Exercise	A	8.53	46,000	392,380	46,000
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Williams Martin D	Sr. VP, Business De ...	Option Exercise	A	8.75	16,250	142,188	16,250
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Rieder Wendy E	VP, IP and Legal, G ...	Option Exercise	A	8.75	22,000	192,500	22,000
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Koya Keizo	Sr. VP, Drug Develo ...	Option Exercise	A	8.75	26,000	227,500	26,000
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Ehrlich Keith S	VP, Fin. and Admin. ...	Option Exercise	A	8.75	22,000	192,500	22,000
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Jacobson Eric W	Sr. VP, Research an ...	Option Exercise	A	8.75	32,500	284,375	32,500
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Barsoum James G	Sr. VP, Research	Option Exercise	A	8.75	23,000	201,250	23,000
Feb 28 2007	SNTA	SYNTA PHARMACEUTIC ...	Chadwick Jeremy G	Sr. VP, Pgm Mgmt an ...	Option Exercise	A	8.75	23,000	201,250	23,000
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	CxSynta LLC	10% Owner	Option Exercise	C	0.00	2,154,105	0	0
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	CxSynta LLC	10% Owner	Buy	C	0.00	1,690,646	0	7,761,716	6.1 M to 7.8 M (+27.85 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Option Exercise	C	0.00	2,154,105	0	0
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Option Exercise	C	0.00	30,131	0	0
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	C	0.00	1,690,646	0	7,761,716	6.1 M to 7.8 M (+27.85 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	P	10.00	720,000	7,200,000	831,602	111.6 K to 831.6 K (+645.15 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Buy	C	0.00	23,648	0	111,602	88 K to 111.6 K (+26.89 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Kovner Bruce	Director	Grant	A	0.00	2,857	0	87,954	85.1 K to 88 K (+3.36 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Option Exercise	C	0.00	67,495	0	0
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Buy	P	10.00	100,000	1,000,000	346,057	246.1 K to 346.1 K (+40.64 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Buy	C	0.00	52,973	0	246,057	193.1 K to 246.1 K (+27.44 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	WILSON ROBERT N	Director	Grant	A	0.00	2,857	0	193,084	190.2 K to 193.1 K (+1.50 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Option Exercise	C	0.00	300,000	0	0
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	P	10.00	180,000	1,800,000	1,330,970	1.2 M to 1.3 M (+15.64 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Buy	C	0.00	235,454	0	1,150,970	915.5 K to 1.2 M (+25.72 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Gollust Keith R	Director	Grant	A	0.00	2,857	0	34,357	31.5 K to 34.4 K (+9.07 %)
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Williams Martin D	Sr. VP, Business De ...	Buy	P	10.00	200	2,000	200	0 to 200
Feb 13 2007	SNTA	SYNTA PHARMACEUTIC ...	Jacobson Eric W	Sr. VP, Research an ...	Buy	P	10.00	300	3,000	25,300	25 K to 25.3 K (+1.20 %)

Page: < prev 1 2 3 4